B02 – MK-2206, a Novel AKT Inhibitor, Suppresses Medullary Thyroid Cancer Proliferation

Published in 2012 Listed under Basic Science, Poster

Jocelyn F. Burke, MD; Logan Schlosser, BS; April Harrison, BS; Muthusamy Kunnimalaiyaan, PhD; Herbert Chen, MD, FACS

  pdf Download Poster (858 KB)

B04 – Regulation of corticotropin releasing hormone (CRH) and urocortin family peptide expression in human carcinoid BON cells

Published in 2012 Listed under Basic Science

Monica C. Chen; Vay Liang W. Go; Hung Pham; Million Mulugeta; Sergio Solorzano; Martin G. Martin; Yvette Taché; S. Vincent Wu

B05 – Ki-67 Index Variability in Neuroendocrine Tumors

Published in 2012 Listed under Basic Science

Jeffrey Craig; Simron Singh; Calvin Law; Matthew Cheung

B06 – Olfactory Receptor 51E1 is a Potential Novel Tissue Biomarker for the Diagnosis and Prognosis of Small Intestine Neuroendocrine Tumors

Published in 2012 Listed under Basic Science

Tao Cui; Apostolos V. Tsolakis; Janet Cunningham; Su-Chen Li; Thomas Lind; Kjell Öberg; Valeria Giandomenico

B07 – mTOR Pathway Proteins are Not Upregulated in SDHB-Related Paragangliomas: Relevance to Future Therapeutic Options Using mTOR Inhibitors

Published in 2012 Listed under Basic Science

Hans K. Ghayee; Alessio Giubellino; Arielle Click; Payal Kapur; Victoria Martucci; Jerry W. Shay; Rhonda F. Souza; Karel Pacak

B08 – Affinity Proteomic Plasma Analysis of Small Intestinal Neuroendocrine Tumors

Published in 2012 Listed under Basic Science, Poster

Affinity Proteomic Plasma Analysis of Small Intestinal Neuroendocrine Tumors

  pdf Download Poster (1.30 MB)

B10 – Potential Use of Xanthohumol in Carcinoid Cancer

Published in 2012 Listed under Basic Science, Poster

April D. Harrison; Mary Ndiaye; Catherine M. McManus; Nicole L. Seiler; Herbert Chen; Muthusamy Kunnimalaiyaan

  pdf Download Poster (710 KB)

B11 – G3 Neuroendocrine Neoplasms (G3 NENs) with Deceptively Well-Differentiated Histologic Features Have a Poor Outcome

Published in 2012 Listed under Basic Science, Poster

Lily Jih, MD; Richard Mertens, MD, PhD; Run Yu MD, PhD; Edward Wolin, MD; Deepti Dhall, MD

  pdf Download Poster (1.83 MB)

B12 – Global MicroRNA Profiling of Small Intestine Neuroendocrine Tumors (SI-NETs) and Establishment of a Method to Study Serum MicroRNA Expression from the Same Tumors

Published in 2012 Listed under Basic Science, Poster

Su-Chen Li; Cécile Martijn; Ahmed Essaghir; Ricardo V. Lloyd; Jean-Baptiste Demoulin; Kjell Öberg; Valeria Giandomenico

  pdf Download Poster (1.29 MB)

B15 – Loss of Succinate Dehydrogenase (SDHB) Expression in Midgut Carcinoids as Prognostic Factor: A New Marker of Personalized Cancer Medicine in Neuroendocrine Tumors?

Published in 2012 Listed under Basic Science, Poster

Massimo Milione; Sara Pusceddu; Roberto Buzzoni; Angela Damato; Emanule Meroni; Alfonso Marchian ò; Barbara Formisano; Ettore Seregni; Filippo G. de Braud; Jorgelina C. Coppa; Vincenzo Mazzaferro; Giuseppe Pelosi

  pdf Download Poster (350 KB)

B16 – A New Animal Model for the Identification of Novel Signaling Mechanisms Mediating Medullary Thyroid Carcinoma

Published in 2012 Listed under Basic Science, Poster

Karine Pozo; Emely Castro-Rivera; Roswitha Pfragner; Fiemu Ejiogu Nwariaku; James Allen Bibb

  pdf Download Poster (990 KB)

B18 – Expression of MTOR Pathway Components and Association with Clinical Outcomes in Neuroendocrine Tumors

Published in 2012 Listed under Basic Science

Zhi Rong Qian; Monica Ter-Minassian; Jennifer A. Chan; Yu Imamura; Susanne M. Hooshmand; Aya Kuchiba; Teppei Morikawa; Lauren K. Brais; Anastassia Daskalova; Rachel Heafield; Xihong Lin; David C. Christiani; Charles S. Fuchs; Shuji Ogino; Matthew H. Kulke

B19 – Use of a 92-gene Molecular Classifier to Predict the Site of Origin for Primary and Metastatic Tumors with Neuroendocrine Differentiation

Published in 2012 Listed under Basic Science, Poster

Catherine A. Schnabel, PhD; Sarah E. Kerr, MD; Peggy Sullivan, MD; Yi Zhang, PhD; Veena Singh, MD; Brittany Carey; Mark G. Erlander, PhD; W. Edward Highsmith, PhD; Elena F. Brachtel, MD; Sarah M. Dry, MD

  pdf Download Poster (805 KB)

B20 – Targeting Achaete-scute Complex-like1 (ASCL1): A Regulator of Carcinoid Growth and Phenotype

Published in 2012 Listed under Basic Science

Yash Somnay, BS; Jake Eide, BS; Renata Jaskula-Sztul, PhD; April Harrison, BS; Kevin Simon, BS; Selvi Kunnimalaiyaan, MS; Herbert Chen, MD, FACS; Muthusamy Kunnimalaiyaan, PhD

C01 – Laboratory Diagnosis of Gastrinoma Remains Difficult

Published in 2012 Listed under Clinical, Poster

Joy Ardill; Lee Armstrong; Brian Johnston; David McCance

  pdf Download Poster (81 KB)

C05 – An Expert Panel Consensus on Medical Treatement of Non-Midgut Unresectable Neuroendocrine Tumors

Published in 2012 Listed under Clinical, Poster

Al B. Benson; Jonathan R. Strosberg; George A. Fisher; Jennifer L. Malin; Lowell B. Anthony; Bulent Arslan; John F. Gibbs; Edward Greeno; Renuka V. Iyer; Michelle K. Kim; William J. Maples ; Philip. A. Philip; Edward M. Wolin; Dasha Cherepanov; Michael S. Broder

  pdf Download Poster (291 KB)

C06 – Description of Initial Treatment for Newly Diagnosed Metastatic Carcinoid (cNET) and Pancreatic Neuroendocrine (pNET) Patients

Published in 2012 Listed under Clinical, Poster

Sarah Bobiack, PhD; Michael A. Choti, MD; Al B. Benson, III MD; Jonathan R. Strosberg, MD; P. Mark Bloomston, MD; Emily K. Bergsland, MD; Carrie C. Zornosa, MSPH; Matthew H. Kulke, MD; Eric K. Nakakura, MD; Manisha H. Shah, MD; James C. Yao, MD

  pdf Download Poster (862 KB)

C07 – Resection of Liver Metastasis in Midgut Neuroendocrine Tumors Affects 10-Year Survival

Published in 2012 Listed under Clinical, Poster

J. Philip Boudreaux MD; Anne E. Diebold BS; Yi-Zarn Wang MD; Eugene A. Woltering MD

  pdf Download Poster (211 KB)

C08 – Lymph Node Positivity in Patients with Small T1 and T2 Midgut Neuroendocrine Tumors

Published in 2012 Listed under Clinical, Poster

J. Philip Boudreaux MD; Yi-Zarn Wang MD; Anne E. Diebold BS; Eugene A. Woltering MD

  pdf Download Poster (190 KB)

C09 – Preliminary Experience with Intra-arterial I-131 MIBG Hepatic Infusion for Progressive Metastatic Low Grade Neuroendocrine Tumors: An Ongoing Work-In-Progress

Published in 2012 Listed under Clinical, Poster

Richard J Campeau, MD, FACNM; Adam M Dowling, MD, FACR; Eugene A Woltering MD, FACS; J Philip Boudreaux, MD, FACS; Yi-Zarn Wang, MD, FACS; Maria M Chester, RN, BSN

  pdf Download Poster (414 KB)

C10 – Prevalence of Functional Tumors in Neuroendocrine Carcinoma: An Analysis from the NCCN NET Database.

Published in 2012 Listed under Clinical, Poster

Michael A. Choti, MD; Sarah Bobiak, PhD; Jonathan R. Strosberg, MD; Al B. Benson, III, MD; P. Mark Bloomston, MD; James C. Yao, MD; Carrie C. Zornosa, MSPH; Emily K. Bergsland, MD; Matthew H. Kulke, MD; Eric K. Nakakura, MD; Manisha H. Shah, MD

  pdf Download Poster (633 KB)

C11 – Neuroendocrine Tumors: A Review of the Sunnybrook Odette Cancer Centre Database

Published in 2012 Listed under Clinical

Jeffrey Craig; Simron Singh; Calvin Law; Matthew Cheung

C12 – The Risk of Adenocarcinoma of the Stomach in Type I Carcinoid

Published in 2012 Listed under Clinical, Poster

Michelle Cramblitt, RN; Matthew M. Eves, MD, FACG

  pdf Download Poster (223 KB)

C13 – Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTA Octreotate for Somatostatin Receptor-expressing Neuroendocrine Tumors: The First U.S. Experience

Published in 2012 Listed under Clinical, Poster

Ebrahim S. Delpassand; Amin Samarghandi; Sara Zamanian; Jack Erion; Jim Somone; Robert Wolfangel; Edward M. Wolin; Gregory D. Espenan

  pdf Download Poster (306 KB)

C14 – Management of Breast Metastases from Gastroenteropancreatic Neuroendocrine Tumor Origin

Published in 2012 Listed under Clinical, Poster

Jeremiah L. Deneve, DO; Larry Kvols, MD; Marilyn M. Bui, MD; Jonathan R. Strosberg, MD; John V. Kiluk, MD; Christine Laronga, MD; Marie C. Lee, MD; Nazanin Khakpour, MD

  pdf Download Poster (1.04 MB)

C15 – A Single Fasting Plasma 5-HIAA Value Correlates with 24-Hour Urinary 5-HIAA Values and Other Biomarkers in Midgut Neuroendocrine Tumors (NETs)

Published in 2012 Listed under Clinical, Poster

Anne E. Diebold BS; Maria R. Tellez PhD; Gregg Mamikunian, MS; Vay Liang W. Go, MD; Thomas M. O’Dorisio, MD; Aaron I. Vinik, MD PhD; Eugene A. Woltering, MD

  pdf Download Poster (229 KB)

C16 – Development and Preclinical Evaluation of the New Pan-Somatostatin PET Imaging Probe 68Ga-DOTA-SOM230 (SOMscan®)

Published in 2012 Listed under Clinical, Poster

Melpomeni Fani; Eleni Gourni; Friederike Braun; Anika Mann;rea Kliewer; Jens Kaufmann; Angela Dreykluft; Wolfgang A. Weber; Hakim Bouterfa; Stefan Schulz; Helmut R. Maecke

  pdf Download Poster (837 KB)

C17 – Expert Panel Consensus Statements on the Medical Treatment of Unresectable Pancreatic Neuroendocrine Tumors

Published in 2012 Listed under Clinical, Poster

George A. Fisher; Jonathan R. Strosberg; Al B. Benson; Jennifer L. Malin; Lowell B. Anthony; Bulent Arslan; John F. Gibbs; Edward Greeno; Renuka V. Iyer; Michelle K. Kim; William J. Maples ; Philip. A. Philip; Edward M. Wolin; Dasha Cherepanov; Michael S. Broder

  pdf Download Poster (285 KB)

C18 – KI-67 Heterogeneity in Gastro-Entero-Pancreatic Neuroendocrine Tumors

Published in 2012 Listed under Clinical, Poster

Federicca Grillo; Manuela Albertelli; Paola Calamaro; Borra Tiziana; Sara Bruno; Luca Mastracci; Roberto Fiocca; Diego Ferone

  pdf Download Poster (730 KB)

C19 – Multi-center Phase II Trial of Temsirolimus (TEM) and Bevacizumab (BEV) in Pancreatic Neuroendocrine Tumor (PNET): Results of a Planned Interim Efficacy Analysis

Published in 2012 Listed under Clinical, Poster

Timothy Hobday MD; Rui Qin PhD; Diane Reidy MD; Malcolm Moore MD; Jonathan Strosberg MD;reas Kaubisch MD; Manisha Shah MD; Hedy Kindler MD; Heinz-Joseph Lenz MD; Helen Chen MD; Charles Erlichman MD

  pdf Download Poster (632 KB)

C21 – Effect of Short-term Proton Pump Inhibitor Treatment and Its Discontinuation on Chromogranin A in Healthy Subjects

Published in 2012 Listed under Clinical, Poster

Walter Kocha MD; Hala H. Mosli MBBS, FRCP(c), ABIM, ABEM, Cert Endo; Alan Dennis PhD, FCACB, MBA ; Linda J. Asher RN; Stan H.M. Van Uum, MD PhD, FRCP(c)

  pdf Download Poster (2.00 MB)

C23 – A Multi-Institutional Phase II Open-Label Study of AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Published in 2012 Listed under Clinical

Matthew H. Kulke; Jennifer A. Chan; David P. Ryan; Jeffrey A. Meyerhardt; Charles S. Fuchs; Thomas Abrams; Eileen Regan; Rachel Brady; Jill Weber; Tiffany Campos; Larry K. Kvols; Jonathan R. Strosberg

C24 – The Prevalence of Over the Counter Medication Use Among Patients with Midgut Neuroendocrine Tumors

Published in 2012 Listed under Clinical

Erika B. Lindholm, MD; Maneesh K. Gupta, MD; Anne Diebold BS; JP Boudreaux MD; Yi Z. Wang, MD; Eugene A. Woltering MD

C25 – Surveillance of Small Rectal Carcinoid Tumors in the Absence of Metastatic Disease

Published in 2012 Listed under Clinical, Poster

Sara E. Murray, MD; Rebecca S. Sippel, MD, FACS; Ricardo Lloyd, MD., PhD; Herbert Chen, MD, FACS

  pdf Download Poster (2.66 MB)

C26 – Telotristat Etiprate Produces Clinical and Biochemical Responses in Patients with Carcinoid Syndrome: Update of a Phase 2, Multicenter, Open-label, Serial-ascending, European Study

Published in 2012 Listed under Clinical

Marianne Pavel; Bertram Wiedenmann; Martyn Caplin, Dieter Hoersch; Joel Freiman; Linda Law; Phillip Banks; Kenny Frazier; Jessica Jackson; Brian Zambrowicz

C27 – Interim Results of an Open-Label, Single-Arm Trial of Ultratrace I-131-Iobenguane in Patients with Metastatic Pheochromocytoma/Paraganglioma (Pheo)

Published in 2012 Listed under Clinical, Poster

Daniel A Pryma; R Edward Coleman; Richard Noto; Rodolfo F Perini; Camilo Jimenez; Miguel Pampaloni; Aldo Serafini; Richard Wahl; Lale Kostakoglu; Perry W.Grigsy; Julie Schwarz; Kathy Ford; Jennifer Conley; Norman LaFrance; John Barrett; John Babich

  pdf Download Poster (223 KB)

C28 – Outcomes After Liver Resection and Multidisciplinary Management of Gastroenteropancreatic Neuroendocrine Tumour Liver Metastases

Published in 2012 Listed under Clinical, Poster

Adam Fehr; Pankaj Bhatia; Daryl Gray; Walter Kocha; Robin Reid; James Elliott; Amol Mujoomdar; Christopher Howlett; Douglas Quan

  pdf Download Poster (650 KB)

C29 – Factors Associated with Octreotide LAR Use Among Elderly Patients with Carcinoid Syndrome: A Population-Based Analysis

Published in 2012 Listed under Clinical

Chan Shen; Ying Xu; Colleen C. Leary; James C. Yao; Ya-Chen Tina Shih

C30 – Clinical, Pathologic, and Biologic Characterization of WHO Grade 3, Non-Small Cell and Non Large Cell Neuroendocrine Carcinoma of the Pancreas

Published in 2012 Listed under Clinical

Chanjuan Shi; Jesse Wright; Frank Revetta; Eric Liu; Alex Parikh; Kay Washington; Nipun Merchant

C32 – Epidemiology of Neuroendocrine Tumors in Ontario: A 15-Year Population-Based Study

Published in 2012 Listed under Clinical, Poster

Simron Singh; Refik Saskin; Ning Lin; Moises Cukier; Calvin Law

  pdf Download Poster (2.45 MB)

C33 – Patterns of Care of Neuroendocrine Cancer in Ontario: Health Services Delivery

Published in 2012 Listed under Clinical, Poster

Simron Singh; Refik Saskin; Ning Lin; Moises Cukier; Calvin Law

  pdf Download Poster (1.05 MB)

C34 – Survival of Patients with Neuroendocrine Cancers in Ontario Over Last 15 Years

Published in 2012 Listed under Clinical, Poster

Simron Singh; Refik Saskin; Ning Lin; Moises Cukier; Calvin Law

  pdf Download Poster (1.24 MB)

C35 – Review of 126 High Grade Neuro-Endocrine Carcinomas of the Colon and Rectum

Published in 2012 Listed under Clinical, Poster

James D. Smith; Diane L. Reidy; Martin Weiser; Larissa K. Temple; Jose G. Guillem; Philip B. Paty; Garrett M. Nash

  pdf Download Poster (248 KB)

C36 – Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3)

Published in 2012 Listed under Clinical, Poster

Halfdan Sorbye; Staffan Welin; Seppo Langer; Lena Vestermark; Nanna Holt; Pia Osterlund; Svein, Dueland; Eva Hofsli; Marianne Guren; Katarina Ohrling; Elke Birkemeyer; Espen Thiis-Evensen; Matteo Biagini; Henning Gronbaek; Leena-Maija Soveri; Ingrid Holst Olsen; Birgitte Federspiel; Jurg Assmus; Eva Tiensuu Janson; Ulrich Knigge

  pdf Download Poster (295 KB)

C38 – Expert Panel Consensus Statements on the Medical Treatment of Unresectable Midgut Gastrointestinal Neuroendocrine Tumors

Published in 2012 Listed under Clinical, Poster

Jonathan R. Strosberg; George A. Fisher; Al B. Benson; Jennifer L. Malin; Lowell B. Anthony; Bulent Arslan; John F. Gibbs; Edward Greeno; Renuka V. Iyer; Michelle K. Kim; William J. Maples; Philip A. Philip; Edward M. Wolin; Dasha Cherepanov; Michael S. Broder

  pdf Download Poster (278 KB)

C39 – Prognostic Validity of the American Joint Committee on Cancer (AJCC) Staging Classification for Midgut Neuroendocrine Tumors

Published in 2012 Listed under Clinical

Jonathan Strosberg, MD; Jill Weber, MPH; Max Feldman, MD; Larry Kvols, MD

C40 – Treatment of Metastatic Neuroendocrine Tumors of the Thymus with Capecitabine and Temozolomide: A Case Series

Published in 2012 Listed under Clinical

Jonathan Strosberg, MD; Vita Saranga-Perry, MD; Brian Morse, MD; Barbara Centeno, MD; Larry Kvols MD

C41 – Duration and Type of Presenting Symptoms in Patients with Neuroendocrine Tumor (NET)

Published in 2012 Listed under Clinical, Poster

Monica Ter-Minassian; Jennifer A. Chan; Susanne M. Hooshmand; Lauren K. Brais; Anastassia Daskalova; Rachel Heafield; Laurie Buchanan; Zhi Rong Qian; Xihong Lin ;David C. Christiani; Matthew H. Kulke

  pdf Download Poster (203 KB)

C42 – Diagnostic Performance of Dual Tracer PET/CT in Staging Neuroendocrine Tumors of the Lung

Published in 2012 Listed under Clinical

Giorgio Treglia; Antonella Stefanelli; Giuseppe Cardillo; Filippo Lococo; Guido Rindi; Vittoria Rufini

C43 – The Changing Presentation of Pancreatic Neuroendocrine Tumors: Results of 344 Resected Patients over 30 years

Published in 2012 Listed under Clinical, Poster

Brian R. Untch; Diane L. Reidy-Lagunes; Laura H. Tang; Murray F. Brennan; William R. Jarnagin; Peter J. Allen

  pdf Download Poster (294 KB)

C45 – Surgical Treatment Options for Rectal Carcinoid Cancer: Trans-Anal Excision versus Low Anterior Resection with Total Mesorectal Excision

Published in 2012 Listed under Clinical, Poster

Yi-Zarn Wang DDS, MD; Anne Diebold BS; Philip Boudreaux MD; Daniel Raines MD; Richard Campeau MD; Lowell Anthony MD; Eugene Woltering MD

  pdf Download Poster (177 KB)

C46 – Above-Label Doses of Octreotide-LAR in Patients with Metastatic Small Intestinal Carcinoid Tumors

Published in 2012 Listed under Clinical, Poster

Jill Weber, MPH; Max Feldman, MD; Larry Kvols, MD; Jonathan Strosberg, MD

  pdf Download Poster (443 KB)

C48 – Comparison of Yttirum-90 Microspheres and Transarterial Chemoembolization in the Treatment of Inoperable Metastatic Neuroendocrine Tumors

Published in 2012 Listed under Clinical, Poster

Yuhsin V. Wu MD; Garin Tomaszewski MD; Adrienne E. Groman MS; Renuka V. Iyer MD; Boris W. Kuvshinoff MD, MBA

  pdf Download Poster (119 KB)

C49 – Dosing Patterns of Octreotide LAR Among Elderly Patients with Neuroendocrine Tumors: Analysis of the SEER-Medicare Database

Published in 2012 Listed under Clinical

Ying Xu; Ya-Chen Tina Shih; Colleen C. Leary; Chan Shen; James C. Yao

C50 – RADIANT-4: A Randomized, Double-blind, Multicenter, Phase III Study of Everolimus Versus Placebo in the Treatment of Patients With Advanced Non-functional NET of GI or Lung Origin

Published in 2012 Listed under Clinical

James C Yao; Marianne E Pavel; Nicola Fazio; Matthew Kulke; Simron Singh; Gaurav Shah; Judith Klimovsky; Jonathan Strosberg

C51 – The VEGF Pathway in Pancreatic Neuroendocrine Tumors: Prognostic and Predictive Capacity of Baseline Biomarker Levels on Efficacy of Everolimus Analyzed From the RADIANT-3 Study

Published in 2012 Listed under Clinical

James C. Yao; Manisha Shah; Ashok Panneerselvam; David Chen; Sotirios Stergiopoulos; Tetsuhide Ito; Marianne Pavel

C52 – Is There a Role for Radiation for Neuroendocrine Neoplasm Hepatic Metastases?

Published in 2012 Listed under Clinical, Poster

Rebecca Zener, MD; Michael Lock, MD; Walter Kocha, MD; Robert Reid, MD; Daryl Gray, MD

  pdf Download Poster (436 KB)

C53 – Baseline Demographics of Neuroendocrine Tumor Patients Presenting to Seven National Comprehensive Cancer Network (NCCN) Institutions: Development of a Multi-Institutional Outcomes Database

Published in 2012 Listed under Clinical, Poster

Carrie C. Zornosa, MSPH; Michael A. Choti, MD; Sarah Bobiak, PhD; Matthew H. Kulke, MD; James C. Yao, MD; Emily K. Bergsland, MD; Eric K. Nakakura, MD; P. Mark Bloomston, MD; Al B. Benson, III, MD; Manisha H. Shah, MD; Jonathan R. Strosberg, MD

  pdf Download Poster (618 KB)